Previous close | 22.72 |
Open | 23.64 |
Bid | 23.07 x 300 |
Ask | 23.17 x 300 |
Day's range | 22.94 - 24.60 |
52-week range | 16.95 - 49.50 |
Volume | |
Avg. volume | 1,530,258 |
Market cap | 1.904B |
Beta (5Y monthly) | 1.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.72 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 50.00 |
Ultragenyx (RARE) delivered earnings and revenue surprises of -18.02% and 4.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Beam Therapeutics (BEAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...